| CCKAR |
CCKAR, CCKRA: Cholecystokinin receptor type A |
GPR23 |
LPA4, GPR23, P2RY9: Lysophosphatidic acid receptor 4 |
0.557 |
Evidence |
|
| CCKAR |
CCKAR, CCKRA: Cholecystokinin receptor type A |
PTGFR |
PTGFR: Prostaglandin F2-alpha receptor |
0.557 |
Evidence |
|
| NMBR |
NMBR: Neuromedin-B receptor |
GPR176 |
GPR176: Probable G-protein coupled receptor 176 |
0.557 |
Evidence |
|
| TNFRSF7 |
CD27, TNFRSF7: CD27 antigen precursor |
TNFRSF9 |
TNFRSF9, CD137, ILA: Tumor necrosis factor receptor superfamily member 9 precurs |
0.557 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.557 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
0.557 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
0.557 |
Evidence |
|
| CMKOR1 |
CXCR7, CMKOR1, GPR159, RDC1: C-X-C chemokine receptor type 7 |
CCKAR |
CCKAR, CCKRA: Cholecystokinin receptor type A |
0.557 |
Evidence |
|
| EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
TSHR |
IPI00386365 |
0.557 |
Evidence |
|
| EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.557 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
0.557 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
0.557 |
Evidence |
|
| PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
0.557 |
Evidence |
|
| DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
ADRA2A |
IPI00031712 |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
EDG2 |
EDG2, LPA1: Lysophosphatidic acid receptor Edg-2 |
0.557 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
MTNR1A |
MTNR1A: Melatonin receptor type 1A |
0.557 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
GPR85 |
GPR85, SREB2: Probable G-protein coupled receptor 85 |
0.557 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFRSF11A |
TNFRSF11A, RANK: Tumor necrosis factor receptor superfamily member 11A precursor |
0.557 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFRSF4 |
TNFRSF4, TXGP1L: Tumor necrosis factor receptor superfamily member 4 precursor |
0.557 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFRSF7 |
CD27, TNFRSF7: CD27 antigen precursor |
0.557 |
Evidence |
|
| RXRA |
RXRA, NR2B1: Retinoic acid receptor RXR-alpha |
RELB |
RELB: Transcription factor RelB |
0.557 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
GPR132 |
GPR132, G2A: Probable G-protein coupled receptor 132 |
0.557 |
Evidence |
|
| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.557 |
Evidence |
|